Fangyi Long

819 total citations
38 papers, 574 citations indexed

About

Fangyi Long is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fangyi Long has authored 38 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fangyi Long's work include MicroRNA in disease regulation (5 papers), Ferroptosis and cancer prognosis (5 papers) and Circular RNAs in diseases (5 papers). Fangyi Long is often cited by papers focused on MicroRNA in disease regulation (5 papers), Ferroptosis and cancer prognosis (5 papers) and Circular RNAs in diseases (5 papers). Fangyi Long collaborates with scholars based in China, United States and South Korea. Fangyi Long's co-authors include Ting Wang, Junrong Du, Hong Lin, Di Wang, Hongjing Zhou, Chu Chen, Xiqian Zhang, Dongling Liu, Xi Kuang and Hongtao Xiao and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Fangyi Long

33 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangyi Long China 15 377 141 74 46 43 38 574
Atul Rawat India 16 341 0.9× 105 0.7× 64 0.9× 46 1.0× 49 1.1× 33 767
Yanni Lv China 17 387 1.0× 114 0.8× 112 1.5× 41 0.9× 48 1.1× 39 728
Ramoji Kosuru India 17 393 1.0× 79 0.6× 42 0.6× 41 0.9× 41 1.0× 25 810
Chengmu Hu China 18 387 1.0× 90 0.6× 75 1.0× 57 1.2× 47 1.1× 33 848
Yong Su China 15 365 1.0× 68 0.5× 93 1.3× 49 1.1× 55 1.3× 36 665
Gwi Ran Kim South Korea 18 473 1.3× 76 0.5× 42 0.6× 46 1.0× 121 2.8× 22 818
Yidi Qu China 13 277 0.7× 72 0.5× 66 0.9× 135 2.9× 53 1.2× 19 558
Huafeng Pan China 14 313 0.8× 94 0.7× 96 1.3× 62 1.3× 45 1.0× 47 657

Countries citing papers authored by Fangyi Long

Since Specialization
Citations

This map shows the geographic impact of Fangyi Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyi Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyi Long more than expected).

Fields of papers citing papers by Fangyi Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangyi Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyi Long. The network helps show where Fangyi Long may publish in the future.

Co-authorship network of co-authors of Fangyi Long

This figure shows the co-authorship network connecting the top 25 collaborators of Fangyi Long. A scholar is included among the top collaborators of Fangyi Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangyi Long. Fangyi Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Xiao, et al.. (2025). Kaempferol targets Src to exert its chemopreventive effects on mammary tumorigenesis via regulation of the PI3K/AKT pathway. Phytomedicine. 141. 156701–156701. 1 indexed citations
2.
Zhang, Xiqian, Yaxian Zheng, Yan Yang, et al.. (2025). Abnormal ac4C modification in metabolic dysfunction associated steatotic liver cells. Scientific Reports. 15(1). 1013–1013.
3.
Wang, Huishan, et al.. (2025). Loss of alpha-kinase 1 contributes to the formation of congenital cataracts in mice. Cellular & Molecular Biology Letters. 31(1). 1–1.
4.
Wang, Li, Dongsheng Xiong, Fangyi Long, et al.. (2025). MMP-9 dysregulation and chronic inflammation in polycystic ovary syndrome: linking ovulatory dysfunction to diagnostic implications. Journal of Ovarian Research. 18(1). 247–247.
5.
Li, Mengyang, et al.. (2025). Senkyunolide I targets CXCR4 to attenuate liver fibrosis via suppression of the NLRP3/GSDMD pathway. International Immunopharmacology. 164. 115348–115348. 1 indexed citations
6.
Xiao, Xiao, Fangyi Long, Wen‐Lan Wu, et al.. (2025). Col1A1 as a new decoder of clinical features and immune microenvironment in ovarian cancer. Frontiers in Immunology. 15. 1496090–1496090. 2 indexed citations
7.
8.
Zhang, Lele, et al.. (2024). Unraveling the future: Innovative design strategies and emerging challenges in HER2-targeted tyrosine kinase inhibitors for cancer therapy. European Journal of Medicinal Chemistry. 276. 116702–116702. 3 indexed citations
9.
Wang, Ting, et al.. (2024). Deciphering the impact of circRNA-mediated autophagy on tumor therapeutic resistance: a novel perspective. Cellular & Molecular Biology Letters. 29(1). 60–60. 11 indexed citations
10.
Zhu, Yongxia, et al.. (2024). Exploring the potential of Huangqin Tang in breast cancer treatment using network pharmacological analysis and experimental verification. BMC Complementary Medicine and Therapies. 24(1). 221–221. 3 indexed citations
11.
Yang, Yuxin, et al.. (2024). NKG2D knockdown improves hypoxic-ischemic brain damage by inhibiting neuroinflammation in neonatal mice. Scientific Reports. 14(1). 2326–2326. 2 indexed citations
12.
Wu, Yijin, Liu Wang, Kexin Wang, Junrong Du, & Fangyi Long. (2023). Modulation of Xiongdanjiuxin pills on the gut-liver axis in high-fat diet rats. Life Sciences. 333. 122134–122134. 2 indexed citations
13.
Zhang, Xiqian, Fangyi Long, Ruina Li, et al.. (2022). Tanshinone IIA prevents acetaminophen‐induced nephrotoxicity through the activation of the Nrf2‐Mrp2/4 pathway in mice. Environmental Toxicology. 37(7). 1618–1628. 8 indexed citations
14.
Lin, Hong, et al.. (2022). Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance. Molecular Cancer. 21(1). 148–148. 89 indexed citations
15.
Zhang, Shasha, Fangyi Long, Hong Lin, et al.. (2021). Regulatory roles of phytochemicals on circular RNAs in cancer and other chronic diseases. Pharmacological Research. 174. 105936–105936. 17 indexed citations
16.
Long, Fangyi, Hong Lin, Xiqian Zhang, et al.. (2020). Atractylenolide-I Suppresses Tumorigenesis of Breast Cancer by Inhibiting Toll-Like Receptor 4-Mediated Nuclear Factor-κB Signaling Pathway. Frontiers in Pharmacology. 11. 598939–598939. 39 indexed citations
17.
Chen, Yan, Ningxi Li, Bei Xu, et al.. (2019). Polymer-based nanoparticles for chemo/gene-therapy: Evaluation its therapeutic efficacy and toxicity against colorectal carcinoma. Biomedicine & Pharmacotherapy. 118. 109257–109257. 22 indexed citations
18.
Zhou, Hongjing, Chenye Zeng, Tingting Yang, et al.. (2018). Lentivirus-mediated klotho up-regulation improves aging-related memory deficits and oxidative stress in senescence-accelerated mouse prone-8 mice. Life Sciences. 200. 56–62. 43 indexed citations
19.
Du, Junrong, et al.. (2016). Differences in Proinflammatory Property of Six Subtypes of Peroxiredoxins and Anti-Inflammatory Effect of Ligustilide in Macrophages. PLoS ONE. 11(10). e0164586–e0164586. 30 indexed citations
20.
Du, Junrong, Fangyi Long, & Chu Chen. (2014). Research Progress on Natural Triterpenoid Saponins in the Chemoprevention and Chemotherapy of Cancer. ˜The œEnzymes. 36. 95–130. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atul Rawat Breakdown of academic impact, for papers by Yanni Lv Breakdown of academic impact, for papers by Ramoji Kosuru Breakdown of academic impact, for papers by Chengmu Hu Breakdown of academic impact, for papers by Yong Su Breakdown of academic impact, for papers by Gwi Ran Kim Breakdown of academic impact, for papers by Yidi Qu Breakdown of academic impact, for papers by Huafeng Pan
Rankless by CCL
2026